SSA
MEDP icon

Sierra Summit Advisors’s Medpace MEDP Stock Holding History

Sierra Summit Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,637
Closed -$919K – 208
2025
Q4 		$919K Buy
+1,637
New +$929K 0.14% 102

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sierra Summit Advisors's MEDP Position: Q1 2026 in Review

Sierra Summit Advisors sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,637 shares — an estimated $919K sold.

Sierra Summit Advisors first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $919K in Q4 2025. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Sierra Summit Advisors reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Sierra Summit Advisors sold 1,637 Medpace shares in Q1 2026, an estimated $919K.
  • Sierra Summit Advisors first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
  • Sierra Summit Advisors's Medpace position peaked at $919K in Q4 2025.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Sierra Summit Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.